ArticleNPJ precision oncology2024

Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs.

Amina Jamal Laham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.